Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic Agents.

Literature DB >> 22346334

Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic Agents.

Walter Alexander.

Abstract

Entities: Disease

Year: 2012 PMID： 22346334 PMCID： PMC3278188

Source DB: PubMed Journal: P T ISSN： 1052-1372

× No keyword cloud information.

39 in total

1. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors: A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530

2. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.

Authors: Dragica Kozaric-Kovacic; Nela Pivac
Journal: Int J Neuropsychopharmacol Date: 2006-04-06 Impact factor: 5.176

3. Interventions for war-related posttraumatic stress disorder: meeting veterans where they are.

Authors: Charles W Hoge
Journal: JAMA Date: 2011-08-03 Impact factor: 56.272

4. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Authors: Jonathan Davidson; David Baldwin; Dan J Stein; Enrique Kuper; Isma Benattia; Saeed Ahmed; Ron Pedersen; Jeff Musgnung
Journal: Arch Gen Psychiatry Date: 2006-10

5. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.

Authors: K M Connor; S M Sutherland; L A Tupler; M L Malik; J R Davidson
Journal: Br J Psychiatry Date: 1999-07 Impact factor: 9.319

6. Fluoxetine versus placebo in posttraumatic stress disorder.

Authors: Ferenc Martenyi; Eileen B Brown; Harry Zhang; Apurva Prakash; Stephanie C Koke
Journal: J Clin Psychiatry Date: 2002-03 Impact factor: 4.384

7. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.

Authors: Eileen P Ahearn; Mary Mussey; Catherine Johnson; Amy Krohn; Dean Krahn
Journal: Int Clin Psychopharmacol Date: 2006-01 Impact factor: 1.659

8. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

Authors: P Tucker; R Zaninelli; R Yehuda; L Ruggiero; K Dillingham; C D Pitts
Journal: J Clin Psychiatry Date: 2001-11 Impact factor: 4.384

9. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder.

Authors: Kenneth N Sokolski; Thomas F Denson; Robert T Lee; Christopher Reist
Journal: Mil Med Date: 2003-06 Impact factor: 1.437

10. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.

Authors: K T Brady; S C Sonne; J M Roberts
Journal: J Clin Psychiatry Date: 1995-11 Impact factor: 4.384

16 in total

1. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.

Authors: Sophie E Holmes; Matthew J Girgenti; Margaret T Davis; Robert H Pietrzak; Nicole DellaGioia; Nabeel Nabulsi; David Matuskey; Steven Southwick; Ronald S Duman; Richard E Carson; John H Krystal; Irina Esterlis
Journal: Proc Natl Acad Sci U S A Date: 2017-07-17 Impact factor: 11.205

2. Susceptibility and Resilience to Posttraumatic Stress Disorder-like Behaviors in Inbred Mice.

Authors: Stephanie E Sillivan; Nadine F Joseph; Sarah Jamieson; Michelle L King; Itzamarie Chévere-Torres; Illeana Fuentes; Gleb P Shumyatsky; Alicia F Brantley; Gavin Rumbaugh; Courtney A Miller
Journal: Biol Psychiatry Date: 2017-07-08 Impact factor: 13.382

3. Posttraumatic Stress Disorder: an integrated overview and neurobiological rationale for pharmacology.

Authors: Benjamin Kelmendi; Thomas G Adams; Steven Southwick; Chadi G Abdallah; John H Krystal
Journal: Clin Psychol (New York) Date: 2017-07-18

4. Acute sleep interventions as an avenue for treatment of trauma-associated disorders.

Authors: Kevin M Swift; Connie L Thomas; Thomas J Balkin; Emily G Lowery-Gionta; Liana M Matson
Journal: J Clin Sleep Med Date: 2022-09-01 Impact factor: 4.324

5. Aging and Trauma: Post Traumatic Stress Disorder Among Korean War Veterans.

Authors: Barton W Palmer; Samantha Friend; Steve Huege; Mallory Mulvaney; Albaraa Badawood; Abdulaziz Almaghraby; James B Lohr
Journal: Fed Pract Date: 2019-12

Review 6. PTSD: from neurobiology to pharmacological treatments.

Authors: Benjamin Kelmendi; Thomas G Adams; Stephanie Yarnell; Steven Southwick; Chadi G Abdallah; John H Krystal
Journal: Eur J Psychotraumatol Date: 2016-11-08

7. Paroxetine Can Enhance Neurogenesis during Neurogenic Differentiation of Human Adipose-derived Stem Cells.

Authors: Maliheh Jahromi; Shahnaz Razavi; Nushin Amirpour; Zahra Khosravizadeh
Journal: Avicenna J Med Biotechnol Date: 2016 Oct-Dec

8. Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.

Authors: Nithya Ramakrishnan; Marijn Lijffijt; Charles E Green; Nicholas L Balderston; Nicholas Murphy; Christian Grillon; Tabish Iqbal; Brittany Vo-Le; Brittany O'Brien; James W Murrough; Alan C Swann; Sanjay J Mathew
Journal: Depress Anxiety Date: 2021-07-12 Impact factor: 6.505

9. Dopamine D1R-neuron cacna1c deficiency: a new model of extinction therapy-resistant post-traumatic stress.

Authors: Charlotte C Bavley; Zeeba D Kabir; Alexander P Walsh; Maria Kosovsky; Jonathan Hackett; Herie Sun; Edwin Vázquez-Rosa; Coral J Cintrón-Pérez; Emiko Miller; Yeojung Koh; Andrew A Pieper; Anjali M Rajadhyaksha
Journal: Mol Psychiatry Date: 2020-04-24 Impact factor: 13.437

Review 10. PTSD, a Disorder with an Immunological Component.

Authors: Zhewu Wang; M Rita I Young
Journal: Front Immunol Date: 2016-06-06 Impact factor: 7.561